Temasek Holdings Invests in JW Therapeutics
Posted on 03/08/2018
JW Therapeutics (Shanghai) Co., Ltd (JW Therapeutics), a clinical stage biopharmaceutical company, raised US$ 90 million in a Series A round. JW Therapeutics was formed in 2016 by Juno Therapeutics and WuXi AppTec Group to focus on leading cell-based therapy technologies. Lead investors in the Series A round include Temasek Holdings, Sequoia Capital China, and […]
